The orthopedic giant is acquiring Entellus Medical for $24.00 per share, adding to its ear, nose and throat device portfolio with Entellus platforms including XprESS multi-sinus dilation system and the Latera absorbable nasal implant.
Stryker Corp. says it will bring on a set of ENT technologies that are highly complementary to its current offering with the addition of Entellus Medical Inc. to its organization. The large device firm announced on a definitive agreement Dec. 7 to buy Entellus for $24.00 per share, or an equity value of $662m.
Entellus, founded in 2006 in Plymouth, Minn., and traded on the NASDAQ, markets a broad range of ENT devices, including...
Medicare beneficiaries with tricuspid regurgitation will now have access to an innovative treatment from Abbott that offers a minimally invasive alternative to open-heart surgery.
Waters Corp. will acquire Becton Dickinson’s Biosciences and Diagnostics business for $17.5bn, doubling its TAM to $40B. Analysts praise the flow cytometry addition but see weaker growth in diagnostics.
Under the terms of the new agreement, Philips will also begin bundling essential supplies – including ECG, noninvasive blood pressure (NIBP) components, and batteries – with its Medtronic-enabled monitors.
